Who Paid My Doc
Reprise III
ClinicalTrials.gov NCT02202434
Research payments
$2,938,407
Through program year 2022, $2,938,407 in research payments was reported against Reprise III, across 830 payments, paid by Boston Scientific Corporation.
- Paid by
- Boston Scientific Corporation
- ClinicalTrials.gov
- NCT02202434
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $18,382 | 14 |
| 2021 | Research | $523,472 | 189 |
| 2020 | Research | $933,318 | 271 |
| 2019 | Research | $1,463,235 | 356 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Vivek Rajagopal Atlanta, GA Named on 39 payments
- John Wang Baltimore, MD Named on 32 payments
- John Harrison Durham, NC Named on 28 payments
- Dean Kereiakes Cincinnati, OH Named on 23 payments
- Robert Hebeler Dallas, TX Named on 22 payments
- Michael Reardon Houston, TX Named on 19 payments
- Justin Levisay Evanston, IL Named on 17 payments
- Bruce Rutkin Manhasset, NY Named on 16 payments
- Steven Yakubov Columbus, OH Named on 16 payments
- Celina Yong Palo Alto, CA Named on 16 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.